SCHEMBL16232760

CC(=O)NC1C(O)[C@H](O[C@@H]2OC(CO)[C@H](O)[C@H](O)C2O)C(CO)O[C@H]1OC1[C@@H](OCC2O[C@@H](O[C@@H]3C(CO)O[C@@H](O[C@@H]4C(CO)O[C@@H](C)C(NC(C)=O)[C@H]4O)C(NC(C)=O)[C@H]3O)C(O)[C@@H](OC3O[C@H](CO)[C@@H](O)C(O)C3O[C@@H]3OC(CO)[C@@H](O[C@@H]4OC(CO[C@]5(OC=O)CC(O)[C@@H](C)C([C@H](O)[C@H](O)CO)O5)[C@H](O)[C@H](O)C4O)[C@H](O)C3NC(C)=O)[C@@H]2O)OC(CO)[C@@H](O)[C@@H]1O

nearest known ligand 0.46

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	SELE	P16581	4/20	0.46

▸	SIGLEC7	Q9Y286	6/20	0.46

▸	MAG	P20916	6/20	0.46

▸	SELL	P14151	2/20	0.41

▸	SELP	P16109	1/20	0.41

▸	CD209	Q9NNX6	1/20	0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL16232743	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL17195743	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL16232789	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL16187860	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL18926409	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL16312025	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL18926408	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL12197018	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL16312003	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP
SCHEMBL17195764	1.00	SELE (0.46)	SELESIGLEC7MAGSELLSELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-9422357-B2	Glycosylated polypeptide and drug composition containing said polypeptide	GLYTECH, INC. (JP)	2016-08-23	—	—	US	disclosed
US-20140336116-A1	Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide	GLYTECH, INC. (JP)	2014-11-13	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20140336116-A1	Glycosylated Polypeptide and Drug Composition Containing Said Polypeptide	GIPR, SSTR4, SSTR5	SELE 430/4885SIGLEC7 104/4885MAG 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.